Riehen, Switzerland

Rainer R Kuhn

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rainer R Kuhn. Retrieved from https://idiyas.com/inventor/rainer-r-kuhn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rainer R Kuhn: Innovator in Neurological Treatments

Introduction

Rainer R Kuhn is a notable inventor based in Riehen, Switzerland. He has made significant contributions to the field of medicine, particularly in the treatment of neurological conditions. His innovative work has led to the development of a patent that addresses critical health issues.

Latest Patents

Rainer R Kuhn holds a patent for the "Use of 1-{4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-benzyl}-azetidine-3-carboxylic acid in treating symptoms associated with Rett syndrome." This patent also covers the "Use of an S1P receptor modulator in the treatment or prevention of a disease or condition dependent on brain-derived neurotrophic factor (BDNF) expression." His work in this area is crucial for advancing treatment options for patients suffering from these conditions.

Career Highlights

Rainer R Kuhn is associated with Novartis AG, a leading global healthcare company. His role at Novartis has allowed him to collaborate with other experts in the field and contribute to groundbreaking research and development.

Collaborations

Rainer has worked alongside notable colleagues such as Ruben Deogracias and Yves-Alain Barde. Their combined expertise has fostered an environment of innovation and progress in neurological research.

Conclusion

Rainer R Kuhn's contributions to the field of medicine through his patents and collaborations highlight his commitment to improving health outcomes. His work continues to inspire advancements in the treatment of neurological disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…